美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
55513-112-01	55513-112	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1 SYRINGE in 1 CARTON (55513-112-01) / 1.91 mL in 1 SYRINGE
55513-112-96	55513-112	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1 SYRINGE in 1 CARTON (55513-112-96) / 1.91 mL in 1 SYRINGE
55513-112-99	55513-112	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1.91 mL in 1 SYRINGE (55513-112-99)
55513-100-01	55513-100	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1 VIAL, GLASS in 1 CARTON (55513-100-01) / 1.91 mL in 1 VIAL, GLASS
55513-100-96	55513-100	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1 VIAL, GLASS in 1 CARTON (55513-100-96) / 1.91 mL in 1 VIAL, GLASS
55513-100-99	55513-100	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1.91 mL in 1 VIAL, GLASS (55513-100-99)
55513-123-01	55513-123	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20230214	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1 CARTRIDGE in 1 CARTON (55513-123-01) / 1.91 mL in 1 CARTRIDGE
55513-123-96	55513-123	HUMAN PRESCRIPTION DRUG	TEZSPIRE	tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20240220	N/A	BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210 mg/1.9mL	1 CARTRIDGE in 1 CARTON (55513-123-96) / 1.91 mL in 1 CARTRIDGE